New Kiwi-Based Supplement for Progressive MS: What to Know

Credibility

Interest

Key Takeaway

A new kiwi-based supplement might help manage progressive MS safely.

What They Found

Researchers are testing a new supplement called Forza™, made from special kiwi plant leaves. This supplement contains a protein called osmotin, which helps protect cells and reduce inflammation, similar to how a comforting blanket can help you feel secure. The study will involve 50 patients with progressive MS, who will take the supplement for six months. During this time, doctors will check how safe the supplement is and if it helps with MS symptoms. They will look at various factors, like patients’ brain health and overall well-being, to see how the supplement affects them.

Who Should Care and Why

This study is important for MS patients, especially those with progressive forms of the disease, who often feel stuck without effective treatments. If the supplement works, it could provide a new option to help manage symptoms and improve quality of life, much like finding a new tool that makes a difficult job easier. Caregivers should pay attention too, as they can support their loved ones through this potential new treatment journey. Healthcare providers might also gain insights to better support their patients with progressive MS. Overall, this could change daily routines and improve health outcomes for many living with MS.

Important Considerations

The study is still in the early stages, so we don’t know yet how effective Forza™ will be for everyone. The trial only includes a small group of patients, which means the results may not apply to all MS patients. Additionally, while the initial signs are hopeful, more research is needed to confirm the findings and understand any long-term effects of the supplement.

Categories:

Treatment Updates Clinical Trials Nutrition

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like PloS one often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News